Navigation Links
Data Development Worldwide Helps Pharmaceutical Marketers Optimize Relationship Marketing to Patients
Date:6/22/2009

Patient-360(TM) tool optimizes impact of patient education programs.

NEW YORK, June 22 /PRNewswire/ -- For marketers in the pharmaceutical industry, building relationships directly with patients is a complex process. Data Development Worldwide's Patient-360(TM) market research tool allows pharmaceutical marketers to identify all touch points in the patient pathway and then to prioritize and optimize those interactions. The result is high-impact patient education programs that produce quality interactions and build lasting relationships.

The stakeholder communications landscape in the pharmaceutical industry is becoming increasingly fragmented and diverse. Marketers are finding traditional communication programs focused on healthcare professionals inadequate and are seeking more comprehensive approaches that include connecting with patients to help them understand their conditions, better manage treatments, and achieve better outcomes.

"The traditional top-down marketing paradigm is being replaced by a more comprehensive approach that recognizes the increasing influence patients have in their care," says Chip Lister, managing director of DDW. "For these efforts to be completely optimized it is essential to understand/prioritize the patient pathway."

The patient pathway consists of all touch points related to a patient's experience from the point a medical issue becomes apparent, through diagnosis/treatment, to resolution. DDW's Patient-360(TM) identifies and prioritizes them allowing Pharmaceutical marketers to leverage the most valuable communication opportunities and audience segments.

Patient-360(TM) is part of a comprehensive suite of proprietary tools that DDW offers global marketers to help them address a multitude of development, marketing, and communications issues. DDW continues to set the standard of analytic quality and market research excellence through its unwavering commitment to assessing and upgrading the techniques they employ on behalf of clients.

About Data Development Worldwide

Data Development Worldwide (DDW) is one of the largest independent market research companies in the U.S. The company's proprietary tools provide unique insights, effective processes and unmatched experience resulting in proven return on investment for leading global marketers in categories including: pharmaceuticals, consumer products, financial services, communications, and traditional/new media.

The past year was marked by significant growth for DDW. The firm climbed to No. 30 on the Honomichl listing of the top 50 U.S. market research organizations. Headquartered in New York, DDW employs more than 100 people in key markets throughout the U.S. More information: www.datadw.com.


'/>"/>
SOURCE Data Development Worldwide
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Isolation of a new gene family essential for early development
2. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
3. The Philadelphia Walk Now for Autism Expected to Draw 10,000 Walkers and Raise $1 Million to Help Find Answers About the Nations Fastest-Growing Developmental Disorder
4. Ovation further advances development pipeline with new phase III epilepsy study
5. Pioneer Surgical Technology Hires Vice President of New Business Development
6. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
7. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
8. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
9. Optim To Assist Prairie Community Health Center with Construction Scope Development
10. Nick Childs Joins Grey New York as Director of Content Development
11. New clues to breast cancer development in high-risk women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... 23, 2017 , ... ChenMed, a privately owned medical, management ... strategic executive team expansion needed to further optimize growth and performance. , “We ... Christopher Chen, MD, ChenMed Chief Executive Officer. “George Wheeler and Donald Trexler ...
(Date:3/23/2017)... ... 2017 , ... Sharon Kleyne, host of the nationally syndicated radio program, The ... recently talked on her program about how she is looking forward to World Water ... an important distinction. World Water Day, Kleyne pointed out, is an occasion for looking ...
(Date:3/23/2017)... Los Angeles, CA (PRWEB) , ... March 23, 2017 , ... ... half of all Americans, yet poor sleep is likely not the only cause of ... these undesirable characteristics that make you look older or in poor health are likely ...
(Date:3/23/2017)... ... March 23, 2017 , ... Natural Subsistence, a ... of people’s health and nutrition, announced its product Leyzene is now available for ... develops nutritional supplements that help people improve all aspects of their health so ...
(Date:3/23/2017)... Square, PA (PRWEB) , ... March 23, 2017 , ... ... days. That means many students are thinking about summer internships , which can ... lack thereof). , The pros at Garden Media Group, a boutique public relations firm ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 23, 2017 Global Colposcope Market by Manufacturers, ... Colposcope in Global market, especially in North America ... , South America , Middle East ... the market based on manufacturers, regions, type and application. ... Browse 190 Tables and Figures, ...
(Date:3/23/2017)... March 23, 2017   Casetabs , the pioneer ... mobile app for the iPhone. With this new release, ... and communication for physician offices, ambulatory surgery centers (ASCs) ... offers iPhone users even faster, more reliable access to ... even easier to connect care teams so that surgeries ...
(Date:3/23/2017)... , March 23, 2017 ReNeuron ... its CTX cells in chronic stroke patients, despite not meeting ... primary outcome measure, the Action Research Arm Test (ARAT). As ... to a pivotal controlled clinical study in 2017. Beyond CTX, ... (RP) trial in 2017 and Phase I data from its ...
Breaking Medicine Technology: